Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 10 , ISSUE 1 ( January, 2006 ) > List of Articles


Neuroleptic malignant syndrome in critical care unit

I. Shukla, O. Singh, N. Rehman

Keywords : Neuroleptic malignant syndrome, hypodopaminergic state, antipsychotics.

Citation Information : Shukla I, Singh O, Rehman N. Neuroleptic malignant syndrome in critical care unit. Indian J Crit Care Med 2006; 10 (1):50-52.

DOI: 10.4103/0972-5229.24692

License: CC BY-ND 3.0

Published Online: 01-07-2010

Copyright Statement:  Copyright © 2006; The Author(s).


A 23 yrs old patient presented in unconscious state with subsequent development of extrapyramidal symptoms and hyperthermia. On investigations, he was found to have high CPK levels. He was treated with dopaminergic drugs and improved. Later history of intake of stemetil and antipsychotics was found.

PDF Share
  1. Pelonero AL, Levenson JL, Pandurangi AK. Neuroleptic Malignant Syndrome In: Joseph Anthony B, Young Robert R. Movement disorders in Neurology and Neuropsychiatry. 2nd ed. Blackwell Sciences: 1999.
  2. Desai ND, Mundra VK, Gore YS, Diwan PJ, Jaydeokar SS, Jain V, et al. Neuroleptic malignant syndrome: An experience of four cases. J Assoc Physic India 1998;46:653-4.
  3. Pinto C. Neuroleptic malignant syndrome: An experience of four cases. J Assoc Physicians India 1998;46:585-6.
  4. Gohel D, Shah J, Jhaver U. Neuroleptic Malignant syndrome. J Assoc Physic India 2001;49:494.
  5. Gohel D, Mukherjee S. Neuroleptic Malignant syndrome-atypical presentations. J Assoc Physic India 2001;49:947-8.
  6. Tarsy D, Baldessarini RJ, Tarazi FI. Effects of newer antipsychotics on extra pyramidal functions. CNS Drugs 2002;16:23-45.
  7. Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T. Neuroleptic malignant syndrome and atypical antipsychotic drugs. J Clin Psychiatr 2004;65:464-70.
  8. Caroff SN, Rosenberg H, Mann SC. Neuroleptic Malignant syndrome in the critical care unit. Crit Care Med 2002;11:2609-10.
  9. Berardi D, Amore M, Keck PE Jr, Troia M, Dell′Atti M. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: A case-control study. Biol Psychiatr 1998;44:748-54.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.